Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Nikol Dibus"'
Autor:
Tereza Turkova, Juraj Kokavec, Tomas Zikmund, Nikol Dibus, Kristyna Pimkova, Dusan Nemec, Marketa Holeckova, Livia Ruskova, Radislav Sedlacek, Lukas Cermak, Tomas Stopka
Publikováno v:
Communications Biology, Vol 7, Iss 1, Pp 1-13 (2024)
Abstract The formation of hematopoietic cells relies on the chromatin remodeling activities of ISWI ATPase SMARCA5 (SNF2H) and its complexes. The Smarca5 null and conditional alleles have been used to study its functions in embryonic and organ develo
Externí odkaz:
https://doaj.org/article/fbaf7798104b4faba24bcad1875a3d2d
Autor:
Nikol Dibus, Eliska Zobalova, Mario A. M. Monleon, Vladimir Korinek, Dominik Filipp, Jana Petrusova, Radislav Sedlacek, Petr Kasparek, Lukas Cermak
Publikováno v:
Frontiers in Cell and Developmental Biology, Vol 10 (2022)
The ubiquitin ligase SCFFBXO38 controls centromeric chromatin by promoting the degradation of the ZXDB protein. To determine the importance of this pathway during development, Fbxo38-deficient mice were generated. The loss of FBXO38 resulted in growt
Externí odkaz:
https://doaj.org/article/c206b52ca77042eba37040af3605814f
Publikováno v:
Frontiers in Cell and Developmental Biology, Vol 10 (2022)
Alterations in the gene encoding the E3 ubiquitin ligase substrate receptor FBXO38 have been associated with several diseases, including early-onset motor neuronopathy. However, the cellular processes affected by the enzymatic action of FBXO38 are no
Externí odkaz:
https://doaj.org/article/521401f1bdbd49c28a46501dd9305f1f
SKP1-CUL1-F-box protein (SCF) ubiquitin ligases are versatile protein complexes that mediate the ubiquitination of substrates, which are recognized by their F-box-domain- containing subunits1. One of these substrate receptors is FBXO38. Its gene has
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9db62d03300807afe41b58e21d161b01
https://doi.org/10.1101/2023.03.19.531556
https://doi.org/10.1101/2023.03.19.531556
Autor:
Lucie Lanikova, Jiri Svec, Lucie Janeckova, Vendula Pospichalova, Nikol Dibus, Martina Vojtechova, Dusan Hrckulak, Eva Sloncova, Hynek Strnad, Vladimir Korinek
Hypermethylated in Cancer 1 (HIC1) is an established tumor suppressor, which is frequently inactivated in various cancers. In colorectal carcinoma (CRC), silencing of HIC1 has been recognized as one of the important events in malignant tumor progress
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4c48edb23fb7f520702879aa0f7f141a
https://doi.org/10.1101/2022.07.25.501405
https://doi.org/10.1101/2022.07.25.501405